When comparing DAXXIFY® vs. BOTOX®, patients often want to know whether one injectable lasts longer, works faster, treats more areas, or produces a more natural-looking result. Both are prescription neuromodulators that temporarily reduce muscle activity responsible for certain expression lines, but they are not identical products. DAXXIFY® is a newer option known for its peptide-based formulation and potentially longer-lasting correction of frown lines, while BOTOX® Cosmetic has an extensive history of use and multiple FDA-approved cosmetic treatment areas. The best choice depends on your anatomy, treatment goals, preferred maintenance schedule, medical history, and response to previous injections.
What Are Neuromodulator Injections?
Neuromodulators are injectable medications that temporarily interrupt communication between targeted nerves and muscles. When a facial muscle contracts repeatedly, the overlying skin folds in the same location. Over time, these repeated movements can contribute to visible expression lines, including frown lines, forehead lines, and crow’s feet.
A trained injector can place a neuromodulator into specific muscles to reduce the intensity of those contractions. As the treated muscles relax, the skin above them may appear smoother and more refreshed. The goal is not necessarily to eliminate all facial movement. Thoughtful treatment typically focuses on softening selected movements while maintaining natural expression and facial balance.
DAXXIFY® and BOTOX® Cosmetic are both botulinum toxin type A products. However, each has its own formulation, dosing system, clinical profile, and FDA-approved uses. Their potency units are product-specific and cannot be directly converted or compared unit for unit.
What Is DAXXIFY®?
DAXXIFY® is the brand name for daxibotulinumtoxinA-lanm. It is FDA-approved for the temporary improvement of moderate to severe glabellar lines in adults. Glabellar lines are the vertical lines that form between the eyebrows, commonly called frown lines or “11 lines.” DAXXIFY® is also approved for the treatment of cervical dystonia in adults, although that is a therapeutic use rather than a cosmetic indication.
One of the main characteristics that distinguishes DAXXIFY® from other neuromodulators is its formulation. It uses a proprietary stabilizing peptide rather than human serum albumin as an excipient. The product is formulated without animal-derived components.
DAXXIFY® is often discussed as a longer-lasting neuromodulator. In its cosmetic clinical studies, more than half of treated patients continued to have no or mild frown lines at six months based on both patient and investigator assessments. Results still vary significantly from person to person, and a six-month effect is not guaranteed for every patient.
What Is BOTOX® Cosmetic?
BOTOX® Cosmetic is the brand name for onabotulinumtoxinA. It is one of the most widely recognized neuromodulators in aesthetic medicine and has been used cosmetically for many years.
BOTOX® Cosmetic is FDA approved to temporarily improve the appearance of moderate to severe:
- Frown lines between the eyebrows
- Forehead lines
- Crow’s feet
- Platysma bands connecting the jaw and neck
These indications give BOTOX® Cosmetic a broader range of FDA-approved cosmetic applications than DAXXIFY® currently has.
BOTOX® Cosmetic results generally last approximately three to four months, although duration depends on the treatment area, dose, muscle strength, metabolism, and individual response. FDA clinical studies found that improvement in glabellar line severity could persist for up to 120 days.
DAXXIFY® vs. BOTOX®: Key Differences
Although the products work through a similar biological process, several differences may influence a patient’s decision.
FDA-Approved Cosmetic Areas
DAXXIFY® is currently FDA-approved cosmetically for moderate to severe frown lines between the eyebrows. A provider may discuss other treatment areas, but those uses would be considered off-label.
BOTOX® Cosmetic has FDA approval for frown lines, forehead lines, crow’s feet, and platysma bands. This broader labeling can make BOTOX® an appealing option for patients who want several areas treated during the same appointment.
Off-label treatment is common in medicine, but it requires professional judgment. Patients deserve a transparent explanation of whether a recommended treatment is within the product’s FDA-approved labeling.
Formulation
DAXXIFY® uses a proprietary peptide as part of its formulation. It does not contain human serum albumin.
BOTOX® Cosmetic contains human albumin as an inactive ingredient. Albumin has long been used in pharmaceutical products, but some patients are interested in understanding formulation differences before choosing an injectable.
The presence or absence of albumin does not automatically make one product better or safer for every patient. Medical history, allergies, treatment goals, and provider experience remain more important than any single ingredient distinction.
Expected Duration
Duration is one of the most frequently discussed differences in the DAXXIFY® vs. BOTOX® comparison.
DAXXIFY® may provide improvement for approximately six months in many patients treated for frown lines. Some people may see effects fade sooner, while others may continue to notice improvement beyond that point.
BOTOX® Cosmetic commonly lasts about three to four months. Some patients notice movement returning earlier, while others retain a degree of correction longer.
It is also important to distinguish between peak results and complete return to baseline. Neuromodulator effects typically fade gradually. A patient may begin noticing movement returning before the treatment has fully worn off.
Treatment Frequency
A longer-lasting product may reduce the number of appointments needed throughout the year. Someone who responds well to DAXXIFY® may be able to maintain frown-line results with approximately two treatments annually. A patient using BOTOX® Cosmetic may plan treatments about three or four times per year.
However, fewer visits are not always the primary goal. Some patients prefer the flexibility of a shorter-duration treatment, particularly when trying a neuromodulator for the first time or refining a new aesthetic plan.
Treatment frequency must also follow appropriate medical guidance. BOTOX® Cosmetic treatments are generally spaced at least 90 days apart.
Dosing
DAXXIFY® and BOTOX® use different proprietary potency units. The labeled dose for DAXXIFY® treatment of glabellar lines is 40 units, divided among five injection sites. The labeled BOTOX® Cosmetic dose for glabellar lines is 20 units, also divided among five sites.
This does not mean DAXXIFY® is automatically twice as strong. Botulinum toxin units are not interchangeable among brands. Comparing the unit numbers without considering the product-specific formulation and testing method can be misleading.
Patients are better served by discussing the total treatment plan and expected outcome rather than comparing unit counts alone.
Cost
The cost of either treatment depends on multiple factors, including:
- The product selected
- The treatment area
- The recommended dose
- The injector’s experience
- Geographic location
- Available membership or rewards programs
DAXXIFY® may have a higher treatment cost in some practices because of its dosing and longer expected duration. However, a patient who needs fewer appointments could find that the annual cost is more comparable than the price of a single appointment suggests.
BOTOX® Cosmetic may cost less per individual session, but maintaining continuous results generally requires more frequent treatment. The most useful comparison is often the estimated annual maintenance cost, not simply the price of one visit.
Does DAXXIFY® Work Faster Than BOTOX®?
Both treatments can begin producing visible changes within the first several days.
In DAXXIFY® clinical trial diaries, patients reported measurable improvement as early as two days after treatment.
According to the manufacturer, BOTOX® Cosmetic results for approved facial-line treatments may also begin appearing within one to two days, with results continuing to develop afterward.
Neither product reaches its final outcome immediately. Patients are typically advised to allow time for the neuromodulator to take full effect before evaluating symmetry or deciding whether an adjustment is appropriate. The precise follow-up schedule may vary by provider and treatment area.
Does One Product Look More Natural?
Natural-looking results depend less on the brand name and more on treatment planning, dosing, placement, anatomy, and injector technique.
Either DAXXIFY® or BOTOX® can create an overly restricted appearance if too much product is used or if the injection pattern does not suit the patient’s facial structure. Conversely, either product can deliver subtle improvement when used conservatively and strategically.
A skilled injector evaluates factors such as:
- Muscle strength
- Eyebrow position
- Facial asymmetry
- Eyelid structure
- Existing static lines
- Desired level of movement
- Previous neuromodulator response
Patients should explain whether they prefer very limited movement, moderate softening, or the lightest possible correction. A transparent consultation allows the provider to develop a plan that aligns with those expectations.
What Side Effects Are Possible?
DAXXIFY® and BOTOX® Cosmetic can cause temporary side effects. Common effects associated with injectable neuromodulators may include tenderness, redness, swelling, bruising, or headache.
The DAXXIFY® prescribing information identifies headache, eyelid drooping, and facial weakness or reduced facial muscle movement among reported cosmetic side effects.
BOTOX® Cosmetic may cause injection-site discomfort, headache, dry mouth, tiredness, neck pain, eyelid drooping, eyebrow drooping, dry eyes, or other eye-related symptoms.
Both products carry a boxed warning concerning the potential distant spread of botulinum toxin effects. Symptoms can include generalized weakness, double vision, drooping eyelids, difficulty speaking, difficulty swallowing, or difficulty breathing. These complications can be serious and require prompt medical attention.
Patients should tell their provider about all medications, supplements, previous botulinum toxin treatments, muscle or nerve conditions, swallowing problems, breathing problems, planned surgeries, pregnancy, or breastfeeding. Treatment may not be appropriate for individuals with an infection at the proposed injection site or a known hypersensitivity to ingredients in the selected product.
Which Treatment Is Better for First-Time Patients?
There is no universal answer. Some first-time patients prefer BOTOX® Cosmetic because its typical duration is shorter and it has a long history of cosmetic use. They may feel more comfortable trying a temporary treatment that often fades within approximately three to four months.
Other patients may choose DAXXIFY® because they specifically want the possibility of longer-lasting frown-line improvement and fewer maintenance visits.
A conservative treatment plan is especially important for someone receiving neuromodulator injections for the first time. Starting with carefully selected dosing allows the injector to observe how the patient’s muscles respond. Future treatments can then be refined based on duration, movement, symmetry, and satisfaction.
Who May Prefer DAXXIFY®?
DAXXIFY® may appeal to patients who:
- Primarily want to treat moderate to severe frown lines
- Prefer the possibility of longer-lasting results
- Want fewer maintenance appointments
- Have previously responded well to neuromodulators
- Are interested in its peptide-based formulation
Patients who have an important event several months away may also appreciate a potentially longer treatment window. However, new patients should avoid scheduling their first treatment immediately before a major event because individual responses and side effects cannot be predicted with certainty.
Who May Prefer BOTOX® Cosmetic?
BOTOX® Cosmetic may appeal to patients who:
- Want to treat multiple FDA-approved facial or neck areas
- Prefer a familiar and well-established cosmetic injectable
- Are comfortable scheduling maintenance approximately every three to four months
- Want a shorter-duration option while exploring their ideal result
- Have previously achieved consistent results with BOTOX® Cosmetic
Patients who already know how they respond to BOTOX® may reasonably decide to continue using it. A newer or longer-lasting product is not automatically a better choice when an existing treatment is already delivering predictable, satisfactory results.
Can You Switch Between DAXXIFY® and BOTOX®?
Patients can potentially switch from one neuromodulator to another, but the transition should be managed by a qualified medical provider. The injector needs to know the exact product previously used, the dose, the treatment areas, the date of injection, and how long the results lasted.
It is generally not appropriate to add another neuromodulator simply because the first product has not reached its full effect after only a few days. Treating too soon can increase the risk of excessive weakness, asymmetry, or unwanted restriction.
A provider may recommend waiting until the previous treatment has substantially worn off before switching. The timing depends on the product used, the treatment area, and the patient’s response.
Frequently Asked Questions
Is DAXXIFY® stronger than BOTOX®?
Not necessarily. Their units cannot be compared directly because each product uses its own potency measurement and formulation.
Does DAXXIFY® last longer than BOTOX®?
DAXXIFY® may last around six months for frown lines in many patients, while BOTOX® Cosmetic commonly lasts about three to four months. Individual results vary.
Can DAXXIFY® be used for forehead lines?
Its current FDA-approved cosmetic indication is for moderate to severe glabellar lines. Use in another cosmetic area would be off-label and requires evaluation by a qualified provider.
Which option works faster?
Both may begin producing visible improvement within the first few days. Neither provides an immediate final result.
Is DAXXIFY® more expensive than BOTOX®?
It may cost more per appointment in some practices, but its potentially longer duration could reduce the number of treatments needed annually.
Can DAXXIFY® and BOTOX® be used together?
A medical provider must evaluate the timing, areas, and total exposure. Patients should never receive overlapping neuromodulator treatments without careful professional guidance.
Will either treatment erase deep facial lines?
Neuromodulators primarily reduce muscle movement. Deep lines visible while the face is resting may soften but may not disappear completely. Additional skin treatments may be recommended.
How do I know which injectable is right for me?
A consultation is the best way to compare your anatomy, goals, treatment areas, medical history, preferred duration, and previous response to neuromodulators.
Compare DAXXIFY® and BOTOX® at Goldfingers Aesthetics
Choosing between DAXXIFY® and BOTOX® is a personal decision that deserves a careful, transparent consultation. At Goldfingers Aesthetics, we provide an everyday indulgence designed to leave you feeling invigorated with smoother, refreshed skin and an overall healthier YOU. We believe subtle, understated changes can create the most dramatic differences. Our professional staff of highly trained skin care specialists and doctors combines creativity, specialized knowledge, and licensed training to provide high-quality cosmetic enhancement services. Our attention to detail, artistry, and consistency are reflected throughout our treatments and locations. Schedule a consultation with us today to discuss your goals and determine whether DAXXIFY®, BOTOX®, or another personalized treatment approach may be right for you.